Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?

DOI QR Code

Manapov, Farkhad (Department of Radiation Oncology, University of Munich, Germany) ;
Niyazi, Maximilian (Department of Radiation Oncology, University of Munich, Germany) ;
Li, Minglun (Department of Radiation Oncology, University of Munich, Germany)

Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993;11:336-44. https://doi.org/10.1200/JCO.1993.11.2.336
Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-71. https://doi.org/10.1056/NEJM199901283400403
Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group study 9104. J Clin Oncol 2002;20:3054-60. https://doi.org/10.1200/JCO.2002.12.071
Sun JM, Ahn YC, Choi EK, et al. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer. Ann Oncol 2013;24:2088-92. https://doi.org/10.1093/annonc/mdt140
Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 1997;15:893-900. https://doi.org/10.1200/JCO.1997.15.3.893

The Efficacy of External Beam Radiotherapy for Airway Obstruction in Lung Cancer Patients vol.47, pp.2, 2015, https://doi.org/10.4143/crt.2013.261